| scholarly article | Q13442814 |
| P50 | author | Luis Martinez-Sobrido | Q55189492 |
| Aitor Nogales | Q56528198 | ||
| David J Topham | Q57294998 | ||
| P2093 | author name string | Laura Rodriguez | |
| Marta L DeDiego | |||
| P2860 | cites work | Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study | Q21144595 |
| Human host factors required for influenza virus replication | Q24629972 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Avian Influenza Viruses, Inflammation, and CD8(+) T Cell Immunity | Q26765927 | ||
| Structural basis for suppression of a host antiviral response by influenza A virus | Q27651800 | ||
| Reverse Genetics Approaches for the Development of Influenza Vaccines | Q28076140 | ||
| The multifunctional NS1 protein of influenza A viruses | Q28294201 | ||
| Replication-competent fluorescent-expressing influenza B virus | Q28387786 | ||
| Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development | Q28395006 | ||
| Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS | Q28609773 | ||
| Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs | Q28609836 | ||
| Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems | Q29039793 | ||
| A quantitative proteomic analysis of lung epithelial (A549) cells infected with 2009 pandemic influenza A virus using stable isotope labelling with amino acids in cell culture | Q30224621 | ||
| Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza | Q30331304 | ||
| Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60. | Q30336518 | ||
| The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target. | Q30353557 | ||
| Multiple anti-interferon actions of the influenza A virus NS1 protein | Q30361157 | ||
| Influenza A and B virus intertypic reassortment through compatible viral packaging signals. | Q30364518 | ||
| The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses. | Q30371441 | ||
| Twenty amino acids at the C-terminus of PA-X are associated with increased influenza A virus replication and pathogenicity. | Q30373730 | ||
| Interplay between influenza A virus and host factors: targets for antiviral intervention. | Q30375026 | ||
| PA-X is a virulence factor in avian H9N2 influenza virus. | Q30378192 | ||
| PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models | Q30385984 | ||
| Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein | Q30388846 | ||
| Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. | Q30392964 | ||
| Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus | Q41847342 | ||
| A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence. | Q42202713 | ||
| Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2) | Q64129941 | ||
| Impacts of different expressions of PA-X protein on 2009 pandemic H1N1 virus replication, pathogenicity and host immune responses. | Q30398067 | ||
| A review of adult mortality due to 2009 pandemic (H1N1) influenza A in California | Q30401741 | ||
| Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses | Q30414665 | ||
| cDNA cloning and characterization of a secreted luciferase from the luminous Japanese ostracod, Cypridina noctiluca. | Q33200681 | ||
| Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs | Q33843120 | ||
| Attenuation of equine influenza viruses through truncations of the NS1 protein | Q33843410 | ||
| Innate immunity to influenza virus infection | Q33923354 | ||
| Activation of type I and III interferon signalling pathways occurs in lung epithelial cells infected with low pathogenic avian influenza viruses | Q34217456 | ||
| The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature | Q34596703 | ||
| Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach | Q34820655 | ||
| Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus | Q34999702 | ||
| Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia | Q35053045 | ||
| Replication-competent influenza A viruses expressing a red fluorescent protein | Q35071285 | ||
| Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine | Q35110968 | ||
| Development of live-attenuated arenavirus vaccines based on codon deoptimization | Q35487706 | ||
| PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza A virus in avian species by inhibiting virus replication and host response | Q35640905 | ||
| Selective Degradation of Host RNA Polymerase II Transcripts by Influenza A Virus PA-X Host Shutoff Protein. | Q35915706 | ||
| An overlapping protein-coding region in influenza A virus segment 3 modulates the host response | Q36554219 | ||
| Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines | Q36826849 | ||
| Traditional and new influenza vaccines | Q37035833 | ||
| Protection against lethal influenza with a viral mimic | Q37036766 | ||
| NS1 Protein Mutation I64T Affects Interferon Responses and Virulence of Circulating H3N2 Human Influenza A Viruses. | Q37347309 | ||
| Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences | Q37587170 | ||
| Influenza virus-host interactomes as a basis for antiviral drug development | Q37737812 | ||
| The influenza virus RNA synthesis machine: advances in its structure and function | Q37847896 | ||
| Timing Is Everything: Coordinated Control of Host Shutoff by Influenza A Virus NS1 and PA-X Proteins | Q38422972 | ||
| A live-attenuated influenza vaccine for H3N2 canine influenza virus. | Q38717627 | ||
| Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine | Q38727207 | ||
| Comparing the functions of equine and canine influenza H3N8 virus PA-X proteins: Suppression of reporter gene expression and modulation of global host gene expression | Q38763878 | ||
| The inflammatory response triggered by Influenza virus: a two edged sword. | Q38981754 | ||
| Protection of children against influenza: Emerging problems | Q38995372 | ||
| Generation of Recombinant Influenza Virus from Plasmid DNA | Q39664696 | ||
| Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins | Q39699288 | ||
| NS1 Protein Amino Acid Changes D189N and V194I Affect Interferon Responses, Thermosensitivity, and Virulence of Circulating H3N2 Human Influenza A Viruses | Q40399903 | ||
| A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding | Q40407065 | ||
| Prevention and Control of Seasonal Influenza with Vaccines | Q40607746 | ||
| PA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice | Q40706208 | ||
| Mapping of a Region of the PA-X Protein of Influenza A Virus That Is Important for Its Shutoff Activity. | Q40871573 | ||
| The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA. | Q41347441 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pandemic | Q12184 |
| P577 | publication date | 2017-06-21 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus | |
| P478 | volume | 91 |
| Q89552975 | A Broad and Potent H1-Specific Human Monoclonal Antibody Produced in Plants Prevents Influenza Virus Infection and Transmission in Guinea Pigs |
| Q92538061 | Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins in vitro and in vivo |
| Q57093666 | Functional Evolution of the 2009 Pandemic H1N1 Influenza Virus NS1 and PA in Humans |
| Q58762417 | Host Shutoff in Influenza A Virus: Many Means to an End |
| Q90419091 | Host Single Nucleotide Polymorphisms Modulating Influenza A Virus Disease in Humans |
| Q58566718 | Identification of Amino Acid Residues Responsible for Inhibition of Host Gene Expression by Influenza A H9N2 NS1 Targeting of CPSF30 |
| Q89511393 | Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine |
| Q60959439 | Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins |
| Q58089550 | Mutation of influenza A virus PA-X decreases pathogenicity in chicken embryos and can increase the yield of reassortant candidate vaccine viruses |
| Q59356031 | N-Terminal Acetylation by NatB Is Required for the Shutoff Activity of Influenza A Virus PA-X |
| Q64116962 | Novel Approaches for The Development of Live Attenuated Influenza Vaccines |
| Q64059156 | PA-X antagonises MAVS-dependent accumulation of early type I interferon messenger RNAs during influenza A virus infection |
| Q56563872 | PA-X: a key regulator of influenza A virus pathogenicity and host immune responses |
| Q57466491 | Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine |
| Q40072930 | The K186E Amino Acid Substitution in the Canine Influenza Virus H3N8 NS1 Protein Restores Its Ability To Inhibit Host Gene Expression. |
Search more.